Huining Z. He
Tianjin, 300070, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Sonogenic malate depleting modulator for tumor metabolic reprogramming and antitumor immune activation.
Journal: Bioactive materials
Published: July 22, 2025
Near infrared-emitting persistent luminescent imaging-guided gene/optothermal synergistic therapy for enhancing tumor cell damage.
Journal: Journal of colloid and interface science
Published: May 30, 2025
Carrier-Free Peptide-Daunorubicin-Small Interfering RNA Nanoassembly for Targeted Therapy of Acute Myeloid Leukemia.
Journal: Cyborg and bionic systems (Washington, D.C.)
Published: May 28, 2025
Tumor suppressor protein-inspired peptide for siRNA delivery and synergistic cancer therapy.
Journal: Fundamental research
Published: November 18, 2024
Local therapeutic platform prevents postsurgical GBM recurrence by diminishing GICs and reshaping immunosuppressive microenvironment.
Journal: Nature communications
Published: September 23, 2024
Codelivery of apigenin, FdUMP and CD276 antibody synergistic inhibit colorectal cancer by ferroptosis-apoptosis-pyroptosis and CD276 blockade.
Journal: Asian journal of pharmaceutical sciences
Published: September 14, 2024
Lipid Nanoparticular Codelivery System for Enhanced Antitumor Effects by Ferroptosis-Apoptosis Synergistic with Programmed Cell Death-Ligand 1 Downregulation.
Journal: ACS nano
Published: June 13, 2024
A review on gold nanoparticles as an innovative therapeutic cue in bone tissue engineering: Prospects and future clinical applications.
Journal: Materials today. Bio
Published: December 02, 2023
Lipid core-shell nanoparticles co-deliver FOLFOX regimen and siPD-L1 for synergistic targeted cancer treatment.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 22, 2023
An injectable signal-amplifying device elicits a specific immune response against malignant glioblastoma.
Journal: Acta pharmaceutica Sinica. B
Published: March 15, 2023
Antitumor synergism between PAK4 silencing and immunogenic phototherapy of engineered extracellular vesicles.
Journal: Acta pharmaceutica Sinica. B
Published: January 01, 2023
Preparation of CD33 targeted bispecific- and trispecific-T cell engagers and their cytotoxicity on leukemia cells
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: June 09, 2022
Last Updated: 09/26/2026